{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:37:00Z","timestamp":1786581420839,"version":"build-2736575974"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.omtn.2022.03.009","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T07:24:12Z","timestamp":1647415452000},"page":"231-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Skeletal muscle-specific overexpression of miR-486 limits mammary tumor-induced skeletal muscle functional limitations"],"prefix":"10.1016","volume":"28","author":[{"given":"Ruizhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma H.","family":"Doud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber L.","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikrishna","family":"Nakshatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2022.03.009_bib1","doi-asserted-by":"crossref","first-page":"13948","DOI":"10.18632\/oncotarget.24189","article-title":"MiR-486 as an effective biomarker in cancer diagnosis and prognosis: a systematic review and meta-analysis","volume":"9","author":"Jiang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.omtn.2022.03.009_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12885-017-3753-z","article-title":"Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms","volume":"18","author":"Li","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omtn.2022.03.009_bib3","doi-asserted-by":"crossref","first-page":"e5532","DOI":"10.1371\/journal.pone.0005532","article-title":"Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients","volume":"4","author":"Tanaka","year":"2009","journal-title":"PLoS one"},{"key":"10.1016\/j.omtn.2022.03.009_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2008.08.036","article-title":"The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform","volume":"112","author":"Resnick","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.omtn.2022.03.009_bib5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.omtn.2022.03.009_bib6","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1073\/pnas.1100048108","article-title":"MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer","volume":"108","author":"Boeri","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omtn.2022.03.009_bib7","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1158\/0008-5472.CAN-13-2817","article-title":"Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle","volume":"74","author":"Chen","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2022.03.009_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s13402-014-0176-6","article-title":"Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status","volume":"37","author":"Rask","year":"2014","journal-title":"Cell Oncol. (Dordr)."},{"key":"10.1016\/j.omtn.2022.03.009_bib9","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1158\/1535-7163.MCT-17-0717","article-title":"Pharmacological dual inhibition of tumor and tumor-induced functional limitations in a transgenic model of breast cancer","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omtn.2022.03.009_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/rco2.23","article-title":"Aging-associated skeletal muscle defects in HER2\/Neu transgenic mammary tumor model","volume":"4","author":"Wang","year":"2021","journal-title":"JCSM Rapid Commun."},{"key":"10.1016\/j.omtn.2022.03.009_bib11","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab142","article-title":"Hormonally regulated myogenic miR-486 influences sex-specific differences in cancer-induced skeletal muscle defects","author":"Wang","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.omtn.2022.03.009_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.devcel.2013.12.020","article-title":"Gene regulatory networks and transcriptional mechanisms that control myogenesis","volume":"28","author":"Buckingham","year":"2014","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omtn.2022.03.009_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/cr.2012.174","article-title":"miR-486 sustains NF-kappaB activity by disrupting multiple NF-kappaB-negative feedback loops","volume":"23","author":"Song","year":"2013","journal-title":"Cell Res"},{"key":"10.1016\/j.omtn.2022.03.009_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biocel.2013.12.003","article-title":"Myostatin signaling regulates Akt activity via the regulation of miR-486 expression","volume":"47","author":"Hitachi","year":"2014","journal-title":"Int. J. Biochem. Cel. Biol."},{"key":"10.1016\/j.omtn.2022.03.009_bib15","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1073\/pnas.1000300107","article-title":"Regulation of PI3-kinase\/Akt signaling by muscle-enriched microRNA-486","volume":"107","author":"Small","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omtn.2022.03.009_bib16","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1172\/JCI73579","article-title":"MicroRNA-486-dependent modulation of DOCK3\/PTEN\/AKT signaling pathways improves muscular dystrophy-associated symptoms","volume":"124","author":"Alexander","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2022.03.009_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2044-5040-1-27","article-title":"Regulation of DMD pathology by an ankyrin-encoded miRNA","volume":"1","author":"Alexander","year":"2011","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.omtn.2022.03.009_bib18","article-title":"miR-486 is an epigenetic modulator of Duchenne muscular dystrophy pathologies","author":"Hightower","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2022.03.009_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00305-16","article-title":"Blockade of metallothioneins 1 and 2 increases skeletal muscle mass and strength","volume":"37","author":"Summermatter","year":"2017","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2022.03.009_bib20","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/jnci\/djq344","article-title":"Long-term prognostic role of functional limitations among women with breast cancer","volume":"102","author":"Braithwaite","year":"2010","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.omtn.2022.03.009_bib21","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtn.2022.03.009_bib22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/1078-0432.CCR-16-0940","article-title":"Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy","volume":"23","author":"Shachar","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2022.03.009_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13395-018-0152-3","article-title":"Diversification of the muscle proteome through alternative splicing","volume":"8","author":"Nakka","year":"2018","journal-title":"Skeletal muscle"},{"key":"10.1016\/j.omtn.2022.03.009_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1042\/BJ20141373","article-title":"Conserved proline-directed phosphorylation regulates SR protein conformation and splicing function","volume":"466","author":"Keshwani","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.omtn.2022.03.009_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.molcel.2010.09.018","article-title":"DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization","volume":"40","author":"Reinhardt","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2022.03.009_bib26","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1038\/s41598-019-39522-6","article-title":"Extracellular matrix remodelling induced by alternating electrical and mechanical stimulations increases the contraction of engineered skeletal muscle tissues","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2022.03.009_bib27","article-title":"Systemic actions of breast cancer facilitate functional limitations","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omtn.2022.03.009_bib28","doi-asserted-by":"crossref","first-page":"634853","DOI":"10.3389\/fcell.2021.634853","article-title":"Potential roles of muscle-derived extracellular vesicles in remodeling cellular microenvironment: proposed implications of the exercise-induced myokine, irisin","volume":"9","author":"Darkwah","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omtn.2022.03.009_bib29","first-page":"6561726","article-title":"Exercise-induced irisin, the fat browning myokine, as a potential anticancer agent","author":"Maalouf","year":"2019","journal-title":"J.\u00a0Obes."},{"key":"10.1016\/j.omtn.2022.03.009_bib30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/onc.2013.42","article-title":"Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer","volume":"33","author":"Wang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2022.03.009_bib31","first-page":"3525","article-title":"miR-486-5p inhibits cell proliferation and invasion through repressing GAB2 in non-small cell lung cancer","volume":"16","author":"Yu","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.omtn.2022.03.009_bib32","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2022.03.009_bib33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41467-019-08574-7","article-title":"Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2022.03.009_bib34","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.stem.2018.08.019","article-title":"Impaired Notch signaling leads to a decrease in p53 activity and mitotic catastrophe in aged muscle stem cells","volume":"23","author":"Liu","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2022.03.009_bib35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1021\/cb200171d","article-title":"Kinase consensus sequences: a breeding ground for crosstalk","volume":"6","author":"Rust","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.omtn.2022.03.009_bib36","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2022.03.009_bib37","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1093\/emboj\/cdf639","article-title":"Inhibition of SAPK2a\/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs","volume":"21","author":"Rousseau","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2022.03.009_bib38","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1182\/blood-2014-06-581926","article-title":"MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2022.03.009_bib39","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1186\/s12885-015-1898-1","article-title":"Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics","volume":"15","author":"Provatopoulou","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omtn.2022.03.009_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41467-021-27634-5","article-title":"Skeletal muscle derived Musclin protects the heart during pathological overload","volume":"13","author":"Szaroszyk","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2022.03.009_bib41","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/CIRCRESAHA.117.312624","article-title":"A new secretory peptide of natriuretic peptide family, osteocrin, suppresses the progression of congestive heart failure after myocardial infarction","volume":"122","author":"Miyazaki","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtn.2022.03.009_bib42","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1093\/hmg\/ddu270","article-title":"P38alpha MAPK underlies muscular dystrophy and myofiber death through a Bax-dependent mechanism","volume":"23","author":"Wissing","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2022.03.009_bib43","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1074\/jbc.C700221200","article-title":"Deregulated protein kinase A signaling and myospryn expression in muscular dystrophy","volume":"283","author":"Reynolds","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2022.03.009_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41536-018-0045-4","article-title":"Humanizing the mdx mouse model of DMD: the long and the short of it","volume":"3","author":"Yucel","year":"2018","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.omtn.2022.03.009_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/TACG.S187481","article-title":"Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-alpha2 chain-deficient congenital muscular dystrophy","volume":"12","author":"Nguyen","year":"2019","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.omtn.2022.03.009_bib46","doi-asserted-by":"crossref","first-page":"17496","DOI":"10.1074\/jbc.M116.740308","article-title":"Gadd45a protein promotes skeletal muscle atrophy by forming a complex with the protein kinase MEKK4","volume":"291","author":"Bullard","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2022.03.009_bib47","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1096\/fj.06-7285com","article-title":"Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression","volume":"21","author":"Pescatori","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.omtn.2022.03.009_bib48","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.celrep.2015.10.038","article-title":"SRSF10 plays a role in myoblast differentiation and glucose production via regulation of alternative splicing","volume":"13","author":"Wei","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2022.03.009_bib49","doi-asserted-by":"crossref","first-page":"46126","DOI":"10.1038\/srep46126","article-title":"Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy","volume":"7","author":"Sako","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2022.03.009_bib50","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/mus.21789","article-title":"Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders","volume":"42","author":"Bachinski","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtn.2022.03.009_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semcdb.2015.11.005","article-title":"The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting","volume":"54","author":"Carson","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.omtn.2022.03.009_bib52","doi-asserted-by":"crossref","first-page":"46717","DOI":"10.1038\/srep46717","article-title":"iTRAQ-based proteomic analysis reveals key proteins affecting muscle growth and lipid deposition in pigs","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2022.03.009_bib53","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1017\/jns.2017.59","article-title":"Abnormal carbohydrate metabolism in a canine model for muscular dystrophy","volume":"6","author":"Amaral","year":"2017","journal-title":"J.\u00a0Nutr. Sci."},{"key":"10.1016\/j.omtn.2022.03.009_bib54","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1101\/gad.276733.115","article-title":"Mechanisms of metabolic dysfunction in cancer-associated cachexia","volume":"30","author":"Petruzzelli","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2022.03.009_bib55","doi-asserted-by":"crossref","first-page":"E1655","DOI":"10.1210\/jc.2013-1496","article-title":"Changes in circulating microRNAs are associated with childhood obesity","volume":"98","author":"Prats-Puig","year":"2013","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.omtn.2022.03.009_bib56","doi-asserted-by":"crossref","first-page":"102258","DOI":"10.1016\/j.dsx.2021.102258","article-title":"Serum microRNA-486-5p expression in obese Egyptian children and its possible association with fatty liver","volume":"15","author":"Al Azzouny","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.omtn.2022.03.009_bib57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/DMSO.S187422","article-title":"Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients","volume":"12","author":"Bakr Zaki","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.omtn.2022.03.009_bib58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/CS20180890","article-title":"MicroRNAs and other non-coding RNAs in adipose tissue and obesity: emerging roles as biomarkers and therapeutic targets","volume":"133","author":"Lorente-Cebrian","year":"2019","journal-title":"Clin. Sci. (Lond)."},{"key":"10.1016\/j.omtn.2022.03.009_bib59","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1089\/scd.2011.0429","article-title":"miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose","volume":"21","author":"Kim","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.omtn.2022.03.009_bib60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ki.2012.84","article-title":"Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486","volume":"82","author":"Xu","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtn.2022.03.009_bib61","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI200419992","article-title":"Foxo1 mediates insulin action on apoC-III and triglyceride metabolism","volume":"114","author":"Altomonte","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2022.03.009_bib62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.gene.2005.11.012","article-title":"HMGN1 is dispensable for myogenesis and adipogenesis","volume":"371","author":"Hill","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.omtn.2022.03.009_bib63","doi-asserted-by":"crossref","first-page":"e0191318","DOI":"10.1371\/journal.pone.0191318","article-title":"Inhibition of interleukin-6 decreases atrogene expression and ameliorates tail suspension-induced skeletal muscle atrophy","volume":"13","author":"Yakabe","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2022.03.009_bib64","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ebiom.2015.03.018","article-title":"IL-6 blockade as a therapeutic approach for Duchenne muscular dystrophy","volume":"2","author":"Mammen","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2022.03.009_bib65","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1073\/pnas.1507719112","article-title":"Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy","volume":"112","author":"Hathout","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omtn.2022.03.009_bib66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejcb.2011.09.011","article-title":"Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target","volume":"91","author":"Crescioli","year":"2012","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.omtn.2022.03.009_bib67","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fphys.2014.00170","article-title":"G-CSF does not influence C2C12 myogenesis despite receptor expression in healthy and dystrophic skeletal muscle","volume":"5","author":"Wright","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.omtn.2022.03.009_bib68","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1074\/jbc.M112.419788","article-title":"Interleukin-6\/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration","volume":"288","author":"Zhang","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2022.03.009_bib69","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bbrc.2013.05.018","article-title":"Cancer cachexia decreases specific force and accelerates fatigue in limb muscle","volume":"435","author":"Roberts","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2022.03.009_bib70","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccr.2005.10.004","article-title":"Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia","volume":"8","author":"Acharyya","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omtn.2022.03.009_bib71","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.celrep.2019.07.016","article-title":"Modeling human cancer-induced cachexia","volume":"28","author":"Talbert","year":"2019","journal-title":"Cell Rep."}],"updated-by":[{"DOI":"10.1016\/j.omtn.2022.08.022","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000}}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T13:14:29Z","timestamp":1706706869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253122000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":71,"alternative-id":["S2162253122000580"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2022.03.009","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.omtn.2022.08.022","asserted-by":"object"}]},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal muscle-specific overexpression of miR-486 limits mammary tumor-induced skeletal muscle functional limitations","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2022.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}